Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma’s Aurora Facility

• Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure.
• With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innovation and reinforcing its province’s leadership position in the life sciences.
• This project will create 12 new jobs and protect 183 existing positions, unlocking new market opportunities and strengthening the sector’s competitiveness.

MUMBAI, India, Sept. 29, 2026 /PRNewswire/ — Piramal Pharma Solutions (“PPS”), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (“PPL”) (NSE: PPLPHARMA) (BSE: 543635), today announced that its Aurora, Canada drug substance site has received a $1,753,620 investment from the Ontario government through the Life Sciences Scale-Up Fund (LSSUF), enabling PPS to upgrade site infrastructure and commercialize Ontario-made health technologies for new markets.

With support from the government of Ontario, Piramal Pharma is investing $5,314,000 to upgrade site infrastructure at their Aurora facility, strengthening Ontario’s pharmaceutical manufacturing and bolstering domestic production of APIs. This project will enhance R&D and clinical API production, ensure the commercial availability of critical drug substances, and support a resilient and globally competitive life sciences industry in Ontario. The investment will create 12 new jobs and protect 183 existing positions.

“We are grateful to the Government of Ontario and MPP Dawn Gallagher Murphy for their support of this important investment in our Aurora facility,” said Peter DeYoung, CEO, Piramal Global Pharma. “This funding will help enable Piramal Pharma Solutions to upgrade our site infrastructure, strengthen our manufacturing capabilities, and enhance our ability to serve patients and customers around the world. In addition to supporting business growth, this investment will help advance projects focused on sustainability, operational efficiency, and the modernization of our site, reinforcing our commitment to responsible manufacturing and environmental stewardship.”

“Through the Life Sciences Scale-Up Fund, our government is ensuring that Ontario businesses are positioned to develop, commercialize and deploy new technologies across the health-care system,” said Dawn Gallagher Murphy, Member of Provincial Parliament for Newmarket—Aurora. “With this investment, Piramal will be positioned to turn their latest ideas into market-ready solutions, all while creating good-paying jobs and reinforcing Ontario’s position as a global biomanufacturing and life sciences hub.”

First launched in 2024, the $24 million LSSUF works in tandem with the government’s Health Innovation Pathway to advance the objectives of Phase 2 of Ontario’s Life Sciences Strategy and strengthen Ontario’s position as a global leader in health innovation. Building on the fund’s initial success, the 2026 Ontario Budget invested an additional $24 million to support Ontario companies whose work will accelerate the adoption of innovative technologies in the health-care system and support the province’s broader vision of providing connected, convenient care closer to home.

“Ontario’s life sciences sector plays a critical role in supporting the discovery and development of innovative medicines and technologies, which is why our government is proud to support local companies as they take their Ontario-made products to the next level,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “By investing in Piramal through the Life Sciences Scale-Up Fund, we are scaling up our province’s domestic capacity while further positioning Ontario as a leading jurisdiction for life sciences investment for generations to come.”

By investing in the Aurora site, the Ontario government is strengthening Ontario’s leadership in the life sciences and helping PPS advance next-generation technologies to patients worldwide.

About Piramal Pharma Solutions

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products and services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines and gene therapies, made possible through Piramal Pharma Limited’s subsidiary, Yapan Bio Private Limited.

For more information visit: Piramal Pharma Solutions | LinkedIn| Facebook | X

About Piramal Pharma Limited

 

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the Piramal Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL’s associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market.

For more information, visit: Piramal Pharma | LinkedIn

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ontario-contributes-1-7-million-investment-to-advance-life-sciences-innovation-at-piramal-pharmas-aurora-facility-302893371.html

Frost & Sullivan Welcomes Back Sarwant Singh to Accelerate Digital Innovation and Global Growth

Industry veteran and futurist returns to advance digital platforms, strengthen advisory capabilities and drive new business opportunities

LONDON, Sept. 29, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce the return of Sarwant Singh, an experienced growth strategist, futurist and mobility industry expert, who will play a key role in advancing the company’s digital and AI platform strategy, strengthening its industry Practice Areas and accelerating global business growth.

With over 30 years of experience leading major advisory and transformation engagements, Sarwant brings extensive strategic consulting expertise, particularly in the mobility, industrial, tech and energy sectors. A recognised futurist specialising in foresight and megatrends, he is also the author of two books, New Mega Trends, sold in over 30 countries, and Innovating to Zero.

Sarwant also serves on several corporate and advisory boards, including as a board member of Vasuki, a Rothschild-established fund investing in automotive start-ups globally, and as a non-executive director of Ascenso Tyres.

Based in London, Sarwant’s priorities will include accelerating the development of integrated digital solutions, notably the Frost Transformation Engine and MetaBrain, strengthening the company’s industry capabilities and driving new business development and sales transformation initiatives.

Commenting on his return, Sarwant Singh said:

“I’m delighted to return to Frost & Sullivan at such an exciting time for the business. As AI and digital platforms reshape the research and advisory industry, we have a tremendous opportunity to build on the company’s deep industry expertise and global relationships.

“My focus will be on accelerating our digital platform strategy, strengthening collaboration across our Practice Areas and creating new growth opportunities. I’m particularly looking forward to reconnecting with colleagues and helping deliver innovative, scalable solutions that enable our clients to navigate disruption and achieve sustainable growth.”

Sarwant’s return reinforces Frost & Sullivan’s commitment to combining its established research and advisory expertise with technology-enabled solutions to deliver greater client value and accelerate growth worldwide.

About Frost & Sullivan

Frost & Sullivan, the Growth Pipeline Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. Through Growth Pipeline as a Service, the company provides transformational strategies and best-practice models to identify, prioritise and realise growth opportunities.

Schedule Your Growth Pipeline Dialog™ with Frost & Sullivan.

Media Contact

Kristina Menzefricke

Marketing & Communications

Global Customer Experience

Frost & Sullivan

kristina.menzefricke@frost.com

View original content:https://www.prnewswire.co.uk/news-releases/frost–sullivan-welcomes-back-sarwant-singh-to-accelerate-digital-innovation-and-global-growth-302893289.html

One Understanding, Many Outputs: Iyuno Announces the CLOE Skills Powering Modern Localization

Persistent Contextual Memory lets purpose-built Skills share the same understanding of content across multiple deliverables.

BURBANK, Calif., Sept. 29, 2026 /PRNewswire/ — Iyuno today detailed the first set of 10 CLOE Skills, built around the needs of modern localization and the high-quality outputs required. These first 10 Skills include subtitles and SDH, closed captioning, dubbing and audio description scripts, localization, dialogue and spotting lists, show guides, and sensitive events lists, with additional Skills continuously being developed.

CLOE Skills leverage the persistent understanding of the content through the contextual memory rather than requiring AI to interpret the content from scratch each time.

Most AI workflows still treat each task as a new problem. Content goes in, the system interprets it, produces an output, and the process starts again.

CLOE is built around a different idea: understanding should persist.

Once CLOE builds a Contextual Memory for a title, its understanding of characters, relationships, dialogue, terminology, story events, and creative context can be applied across multiple specialized Skills.

“Subtitling, dubbing, audio description and production scripting require different expertise,” David Lee, Iyuno Founder and CEO, said. “They shouldn’t be treated as one generic AI problem. What they should share is an accurate understanding of the story. Skills let us specialize the execution without rebuilding the intelligence underneath it.”

As CLOE continues to evolve, Iyuno plans to expand its Skills ecosystem across additional creative, operational, and audience-facing applications—enabling content organizations to activate understanding in new ways throughout the content lifecycle.

Build the understanding once. Put it to work everywhere.

For more information about CLOE, visit iyuno.com/cloe.

ABOUT IYUNO

Iyuno (www.iyuno.com) is a leading provider of localization services for the media and entertainment industry. Trusted by top entertainment brands and creators worldwide, Iyuno offers comprehensive end-to-end localization services from 40 offices across 29 countries. Backed by a team of exceptional creative and technical talent, state-of-the-art facilities, and cutting-edge technologies, Iyuno proudly boasts the largest global footprint, amplifying its dubbing, subtitling, and media services offerings. The company is also the creator of CLOE, a contextual intelligence platform that transforms content into structured understanding, enabling AI-powered workflows across localization, accessibility, marketing, and emerging content experiences.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/one-understanding-many-outputs-iyuno-announces-the-cloe-skills-powering-modern-localization-302893190.html

At RelFest Chicago, Relativity Announces KPMG and Three Global Law Firms to Join Relativity claiR Advanced Access Program

News Summary

• At its annual user conference, RelFest Chicago, Relativity announced that KPMG, Latham & Watkins LLP, Ashurst Perkins Coie and Troutman Pepper Locke have joined the Advanced Access program for its conversational AI experience designed specifically for lawyers, Relativity claiR.
• KPMG will serve as the program’s first alliance partner, while Latham & Watkins LLP, Ashurst Perkins Coie and Troutman Pepper Locke join a group of leading global law firms helping shape claiR ahead of its planned general availability in early 2027.
• At RelFest Chicago, attendees can learn more about claiR and explore recent developments across Relativity’s broader product and innovation portfolio, including the launch of Assist, expanded Model Context Protocol (MCP) integrations, Relativity’s plan to bring aiR directly into Microsoft Word through the acquisition of Gavel and investments in legal technology innovators through Rel Labs.

CHICAGO, Sept. 29, 2026 /PRNewswire/ — Relativity, a legal data intelligence company, today announced that KPMG, Latham & Watkins LLP, Ashurst Perkins Coie and Troutman Pepper Locke have joined the Advanced Access program for Relativity claiR, a conversational AI experience designed specifically for lawyers.

KPMG will serve as the program’s first alliance partner, joined by global law firms Latham & Watkins LLP, Ashurst Perkins Coie and Troutman Pepper Locke. These early participants will play a key role in shaping and refining claiR ahead of its planned general availability in early 2027.

“You don’t get the best solutions by working in isolation. You get them by bringing together people who see a problem from different angles,” said Phil Saunders, CEO of Relativity. “On any significant matter, outside counsel and advisors are working from the same record toward a common goal, each accountable for a distinct part of the process. Advanced Access brings both of those parties into the room while we’re building claiR, so we can learn what each of them needs, and how they need to work together. That helps us create something that works in the real world, shaped by people who will actually use it.”

The legal record as an intelligence asset

Relativity claiR gives legal practitioners a simple, intuitive way to engage with the full depth of their matter within the secure, governed AI platform where their most consequential legal data already lives.

A customer’s Relativity aiR environment typically contains vast amounts of legal data, along with the context and work product built around it. This powerful intelligence is only valuable if teams can easily access it and put it to work. With claiR, legal teams can go from plain-language questions to finished work, exploring the record, drawing connections and producing the insights and memos that carry a matter forward.

“We are excited to support claiR as Relativity continues to turn powerful technology into practical value for lawyers,” said David Nides, Global Forensic Technology Leader at KPMG US. “The future of legal technology is not simply finding documents; it is generating actionable intelligence that informs legal strategy and business outcomes.”

Perspectives from legal practice

For the participating law firms, Advanced Access gives practicing lawyers an opportunity to work with claiR and offer their perspectives on how conversational AI can support the realities of legal work.

“In the terabyte-scale environments we encounter in modern litigation, we are constantly challenged by the need to sort through tremendous volumes of highly technical materials in developing arguments and answering pivotal fact questions under tight timelines,” said Hayden Schottlaender, Partner at Ashurst Perkins Coie. “Being able to query and interact with these previously unthinkable datasets using natural language, while likely improving accuracy from a manual review resulting from a traditional query, is revolutionary.”

“Clients don’t just want faster answers, they want answers they can rely on. That’s the standard we hold any new technology to before we incorporate it into how we work,” said Alison Grounds, Managing Partner of Troutman eMerge. “Our case teams eagerly signed up to participate in the Advanced Access program for claiR, putting these advanced features to work and demonstrating how conversational AI can make complex legal data more accessible without sacrificing the governance and defensibility that high-stakes legal work requires.”

The growing community shaping claiR

The four new participants join A&O Shearman, Skadden, Arps, Slate, Meagher & Flom LLP, K&L Gates and Foley & Lardner LLP in the Advanced Access program, which was first announced in August 2026. When generally available, claiR is expected to be included in Relativity aiR integrated pricing at no additional cost.

At RelFest Chicago, Sept. 29-Oct. 1, attendees can learn more about claiR and explore recent developments across Relativity’s broader product and innovation portfolio. These include the recent launch of Assist, expanded Model Context Protocol (MCP) integrations, Relativity’s plan to bring aiR directly into Microsoft Word through the acquisition of Gavel, and investments in emerging legal technology innovators through its Rel Labs investment arm.

To stay informed as development progresses, visit https://resources.relativity.com/relativity-clair-updates-opt-in.html.

About Relativity

Relativity is a leading legal data intelligence company that builds technology to help users organize data, discover the truth, and act on it. Its AI platform, Relativity aiR, transforms complex data into actionable insights at massive scale for litigation, investigations, regulatory inquiries, data breach responses, and other legal use cases. The world’s largest law firms and corporations, government agencies, and a robust network of channel partners rely on Relativity’s legal AI to securely surface and manage the most relevant and impactful information in their matters. The company also expands access to technology by providing its platform at no cost to academic institutions through its Relativity Academic program and to organizations supporting pro bono legal work through its Justice for Change initiative.

CONTACT: PR@relativity.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/at-relfest-chicago-relativity-announces-kpmg-and-three-global-law-firms-to-join-relativity-clair-advanced-access-program-302892289.html

Neeyamo’s Global Payroll Compliance AI Enters Its Third Generation with Multi-Agent Compass

Neeyamo’s Compass turns regulatory change into payroll-ready configuration, cross-checked by a council of AI models.

LOS GATOS, Calif., Sept. 29, 2026 /PRNewswire/ — Neeyamo, the global payroll and Employer of Record provider, today unveiled Compass, the multi-agent AI system now powering compliance across every Neeyamo payroll run in 160+ countries.

Compass reads regulatory change as it is published, determines what it means for each affected payroll, and produces the configuration Neeyamo Payroll™ needs to apply it. Customers never log in to Compass; they experience it as payroll that is right when the rule changes.

Neeyamo was among the first payroll providers to run generative AI in production, deploying regulatory change detection in 2024 while the industry was still evaluating chat assistants. Compass is the third generation: the first detected change, the second monitored it, this one acts.

Compass runs as specialised agents: monitoring agents scan gazettes, tax authorities, labour ministries, and collective bargaining sources; interpretation agents deconstruct each country’s payroll and compliance architecture into a structured blueprint; configuration agents, grounded in the architecture of Neeyamo Payroll™ itself, produce configuration-ready specifications, not summaries; validation agents audit pay registers and reconcile parallel runs before release. A council of large language models generates every interpretation independently; when they disagree, a payroll professional decides.

Since 2024, Neeyamo’s AI has monitored 11,000+ regulatory developments, cut publication-to-recommendation time from three weeks to 48 hours, and produced interpretations reviewers accepted unchanged 94 per cent of the time. Compass also designs new-country implementations and trains associates before a live cycle.

“In 2024 we proved AI could tell us a rule had changed. The harder problem was what to do about it – which countries, which pay elements, with what evidence,” said Shakil Gour, SVP and Head of Payroll Product & Integrations. “Compass understands Neeyamo Payroll the way our engineers do, so its output is a change we can apply, not a memo to interpret. Every recommendation is approved by a payroll professional and scored against what they would have done; autonomy is granted rule by rule, only where that record earns it. That is how AI should be allowed to touch pay.”

About Neeyamo

Neeyamo is a technology-enabled provider of Global Payroll and Employer of Record solutions for multinational and micro-multinational organisations, processing payroll natively across 160+ countries with legal entities in 45. Learn more at www.neeyamo.com.

Media contact: Irene Jones, irene.jones@neeyamo.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/neeyamos-global-payroll-compliance-ai-enters-its-third-generation-with-multi-agent-compass-302893020.html

Project Eleven Acquires Riva Labs to Expand Post-Quantum Research and Engineering

Riva Labs joins Project Eleven as the company brings more specialized post-quantum talent and technology under one roof.

NEW YORK, Sept. 29, 2026 /PRNewswire/ — Project Eleven, the company building post-quantum security infrastructure for digital assets, today announced its acquisition of Riva Labs, expanding its expertise in post-quantum signatures, wallets, MPC, and account abstraction. The acquisition also brings technology and intellectual property developed through Riva’s work across Ethereum and other public blockchains, adding to Project Eleven’s capabilities in post-quantum cryptography and blockchain infrastructure.

Riva Labs has built a reputation for translating post-quantum cryptographic research into practical blockchain systems. Its work spans hash-based post-quantum signatures, post-quantum MPC, account abstraction, wallet infrastructure, and hardware signing, including recent demonstrations of post-quantum signing on consumer hardware.

The addition of Riva expands Project Eleven’s research and engineering bench as the digital asset industry prepares for the complexity of post-quantum migration. Rather than treating signatures, wallets, key management and protocol infrastructure as separate problems, Project Eleven is bringing together expertise across each layer required to make that transition practical.

That work is becoming more urgent as AI accelerates cryptographic research and cryptanalysis, allowing new techniques to be developed, tested, and challenged at greater speed. Riva has made AI a core part of its research and engineering process, bringing that capability into Project Eleven’s work across post-quantum cryptography and crypto agility.

“Riva Labs is exactly the kind of talent we want at Project Eleven: deeply technical and focused on turning cryptographic research into systems that can actually be deployed,” said Alex Pruden, CEO and Co-Founder of Project Eleven. “Bringing Riva into Project Eleven strengthens an already exceptional research and engineering team, adds valuable technology, and accelerates our ability to lead the transition to post-quantum security across digital assets.”

“Project Eleven and Riva Labs came at this problem from different directions and reached many of the same conclusions about what the industry needs,” said Matteo Vena, Co-Founder of Riva Labs. “Upgrading the public networks the future will run on, without compromising the properties that make them valuable in the first place, is a monumental challenge. Our focus is on giving the industry the tools to accelerate that transition, and joining Project Eleven lets us do it at a much larger scale.”

The Riva team and technology will become part of Project Eleven’s broader research and product efforts across post-quantum cryptography, digital asset custody, and blockchain security. The acquisition deepens Project Eleven’s technical capabilities as it builds the infrastructure required for a secure post-quantum transition.

Alex Pruden, Conor Deegan, and Matteo Vena are available for interview.

About Project Eleven

Project Eleven builds resilient infrastructure and tooling for the post-quantum era. The company develops scalable solutions that strengthen security across a rapidly evolving quantum threat landscape. With deep expertise in cryptography, blockchain, and financial systems, Project Eleven bridges advanced post-quantum research with real-world implementations that prepare the digital asset ecosystem for the future. For more information, visit www.projecteleven.com.

About Riva Labs

Riva Labs is a cryptography and protocol engineering team working on post-quantum infrastructure for digital assets, with a particular focus on hash-based signatures. Our work spans software wallets, hardware signers and MPC infrastructure on Ethereum and other public blockchains, and is grounded in our own research. We also contribute to the underlying protocols and to open source software, with the goal of making every layer of the stack more secure against both current and future adversaries.

Media Contacts

Aubrey Strobel / Elena Nisonoff, Halcyon Communications

projecteleven@halcyonpr.xyz

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/project-eleven-acquires-riva-labs-to-expand-post-quantum-research-and-engineering-302892060.html

RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues

Ophthalmologist-developed and clinically tested, the new peptide-powered formula pairs advanced time-release technology with high-performance lash conditioning

VENTURA, Calif., Sept. 29, 2026 /PRNewswire/ — RevitaLash® Cosmetics, the internationally recognized leader in lash, brow, and hair care, is advancing lash innovation once again with the launch of RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, the world’s first time-release multi-peptide lash conditioning serum developed by an ophthalmologist.

Scientifically advanced and clinically tested, the new formula offers a high-performance approach to lash conditioning for consumers seeking the look of stronger, healthier, more bold and resilient lashes without the use of prostaglandins.

At the heart of the formula is RevitaLash Peptide Complex, featuring Revitasome® Technology, Troxerutin and MP17, which combines a protective antioxidant with a biomimetic signal peptide in a time-release liposomal delivery system. Designed to release over eight hours for gentle, optimal absorption into the eyelashes, the peptide-dense, nutrient-rich formula helps support the appearance of natural lash volume while reinforcing strength to help decrease the appearance of fallout and breakage. The result: lashes that look shinier, stronger, more flexible and beautifully conditioned.

“We are proud of this first-of-its kind expansion to our lash serum collection with a formula that brings together advanced science and innovative time-release technology to meet the evolving needs of today’s consumer,” said Lori Jacobus, President and Global CMO of RevitaLash® Cosmetics. “RevitaLash Peptide Complex+ offers a new way to achieve the look of stronger, healthier, beautifully conditioned lashes while delivering the performance, innovation and expertise consumers have come to expect from RevitaLash Cosmetics.”

In a 12-week consumer study of 160 users, RevitaLash Peptide Complex+ delivered visible improvements in the appearance and condition of lashes. After just six weeks, 90% of participants reported improved lash appearance and 90% reported healthier-looking lashes. Additionally, 89% saw enhanced lash appearance at six weeks, increasing to 92% at 12 weeks, while 89% felt their lashes were more nourished at six weeks, increasing to 96% at 12 weeks.

The launch expands RevitaLash Cosmetics’ trusted portfolio of lash conditioners, joining RevitaLash® Advanced, RevitaLash® Advanced Sensitive and RevitaLash® Advanced Pro Eyelash Conditioner, and giving consumers even more choice within the brand’s science-backed lash care collection.

RevitaLash Peptide Complex+ is ophthalmologist-developed, dermatologist-reviewed, hypoallergenic, non-irritating, vegan-friendly and cruelty-free. The formula is also made without parabens, phthalates, gluten, oil and prostaglandin analogues.

RevitaLash Peptide Complex+ Time Release Eyelash Conditioner (4.0 mL / 0.135 fl. oz.) retails for a suggested price of $90.00 and will be available globally beginning 1 October 2026 through authorized salons, spas, specialty retailers and revitalash.com.

About RevitaLash® Cosmetics

RevitaLash Cosmetics is a worldwide leader in developing premium advanced lash, brow and hair beautification products. Founded in 2006 by ophthalmologist Michael Brinkenhoff, M.D., the brand was inspired by his desire to help his wife feel beautiful during her battle with breast cancer. Today, RevitaLash Cosmetics is available in more than 70 countries and is recognized globally for its award-winning products, leading innovation, commitment to safety and its give-back mission supporting breast cancer initiatives through its longstanding Eternally Pink® pledge that has contributed over $14 million to date.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/revitalash-cosmetics-introduces-revitalash-peptide-complex-time-release-eyelash-conditioner-a-revolutionary-lash-serum-made-without-prostaglandin-analogues-302892249.html

STARTRADER Raises Lloyd’s of London Client Fund Insurance to USD 30 Million in Aggregate

The aggregate cover increases thirtyfold from USD 1 million, applies to available balances and open positions in the event of insolvency, and remains free to clients.

PORT LOUIS, Mauritius, Sept. 29, 2026 /PRNewswire/ — Startrader Financial Markets Limited (Mauritius) has raised the aggregate limit of its client fund insurance, underwritten by Arch and other Lloyd’s of London syndicates, from USD 1 million to USD 30 million, effective October 1, 2026. The policy covers available balances and collateral supporting open positions, responding above a per-client retention where insolvency coincides with covered misconduct.

Client fund protection increasingly shapes broker choice. Because insolvency is remote, cover size often goes unexamined until it matters, making early action a governance decision, not a marketing one.

The policy covers only eligible clients of this entity, not other STARTRADER entities, and complements its segregation of client funds from company assets.

“Insurance is not something clients think about on a good day. It matters on the worst one, and a ceiling that only looks adequate until it is tested is not much of a ceiling.”

–  Peter Karsten, CEO, STARTRADER

The higher limit will apply automatically from October 1, 2026, with no action required. Claims must be submitted to the appointed insolvency practitioner, with an Investor Compensation Claim Form, within 12 months of the insolvency event.

About STARTRADER

STARTRADER is a global multi-asset broker empowering retail and institutional partners to access global markets through a range of platforms, including MetaTrader, STARTRADER APP, and STAR Copy. Regulated in five jurisdictions (CMA, ASIC, FSCA, FSA, and FSC), STARTRADER combines strong governance with a client-first approach, serving both retail clients and partners with a commitment to transparency, reliability, and long-term growth.

Disclaimer: This announcement is for information only and is not investment advice or tailored to your circumstances. Forward-looking statements cannot be guaranteed. The insurance is an excess-of-loss policy subject to its full terms, conditions and exclusions, which prevail in any conflict. It covers only loss of client cash or securities caused by covered misconduct following an insolvency event, not trading losses. Payments may be less than a client’s loss and depend on the insolvency practitioner’s determinations and the firm’s policy compliance. Clients are beneficiaries of a discretionary trust with no direct claim against the insurer. CFDs are high risk and may not suit all investors. Not intended for distribution where contrary to local law or regulation.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/startrader-raises-lloyds-of-london-client-fund-insurance-to-usd-30-million-in-aggregate-302892927.html

Yellow.ai Launches Nexus EDGE, the Agentic Desktop Interface That Resolves Employee IT, HR, and Operations Issues — Not Just Answers Them

Deployed to every employee’s computer, Nexus EDGE sees the problem on the device, understands it against the company’s knowledge and systems, and fixes it on the spot — all within the user’s existing permissions

SAN MATEO, Calif., Sept. 29, 2026 /PRNewswire/ — Yellow.ai today announced the launch of Nexus EDGE, an agentic desktop application that brings the company’s Nexus Universal Agentic Interface directly to the employee’s computer. Unlike enterprise search tools and assistants that find an answer and hand the work back to the employee, Nexus EDGE resolves IT, HR, and Operations issues itself — on the actual machine, in real time, and strictly within the role-based permissions the employee already holds.

The launch establishes a new category Yellow.ai calls Employee Experience Automation (EX Automation): the extension of agentic AI from customer experience into the daily working life of every knowledge worker.

“For a decade, employee help tools have competed on how fast they can answer a question,” said Raghu, Co-founder and Chief Executive Officer, Yellow.ai. “But employees were never asking for answers. They were asking to get on with their day. Nexus EDGE is the first interface that closes the gap between knowing the fix and doing the fix — on the device, automatically, and safely.”

The problem EDGE solves. When an employee’s VPN fails before a deployment window, or a new hire’s software won’t install, or finance needs a report from an app they touch twice a year, today’s tools point them to a knowledge-base article and a queue. The answer arrives; the work does not. Nexus EDGE was built to cross that line — from retrieval to resolution.

How it works. Nexus EDGE pairs a cloud reasoning brain, the Nexus Agent, with a local agent that lives on the desktop. EDGE perceives the live screen and application state through built-in computer-use capability and a suite of operating-system-level tools; it reasons over the company’s knowledge base, SOPs, and backend enterprise applications; and when a fix is required, it pulls the correct, current remediation from the Nexus Agent and runs it locally to resolve the issue. The intelligence sits in the cloud, the hands sit on the desktop, and the two operate as one system.

Security as the boundary, not a feature. Every action Nexus EDGE takes is scoped to the role-based access controls of the signed-in user. EDGE acts as that employee, within their permissions, and never beyond them — giving security teams governed, auditable automation without privilege escalation.

What it delivers. In early deployments, Nexus EDGE targets resolution of common employee issues on the device without a ticket, reduces L1 ticket volume to IT and HR teams, and returns multiple hours per employee per year to productive work.

“Nexus changed how enterprises handle customer conversations. Nexus EDGE does the same thing for the people inside the enterprise,” said Rashid Khan, Co-founder and Chief Marketing Officer, Yellow.ai. “We stopped building tools that watch employees work, and built one that does the work with them.”

Nexus EDGE is available now for enterprise deployment. To request a demo, visit yellow.ai/nexus-edge.

About Yellow.ai

Yellow.ai (Bitonic Technology Labs Inc.) is an enterprise agentic AI platform serving 650+ customers across the US, Middle East, India, Asia-Pacific, and South America. Its Nexus Universal Agentic Interface powers autonomous customer and employee experiences at scale across voice, chat, and now the desktop. Learn more at yellow.ai.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/yellowai-launches-nexus-edge-the-agentic-desktop-interface-that-resolves-employee-it-hr-and-operations-issues–not-just-answers-them-302892990.html

CAS announces collaboration with Novartis to advance AI-ready reaction informatics

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis 

COLUMBUS, Ohio, Sept. 29, 2026 /PRNewswire/ — CAS, a division of the American Chemical Society, today announced a collaboration with Novartis Biomedical Research focused on enhancing reaction data accessibility and supporting AI-enabled research. The initiative will leverage CAS unique scientific data curation expertise and science-smart technology to give Novartis researchers integrated, searchable access to proprietary experimental reaction data alongside more than 160 million+ scientist-curated reactions from the authoritative CAS Content Collection™. 

Scientific research generates valuable reaction data stored across a variety of research systems and repositories, including electronic lab notebooks, reports, shared drives, and partner platforms. Bringing information from these sources together can help researchers more efficiently discover, access, and analyze reaction data across the research enterprise. Foundational to this collaboration is the application of CAS data transformation services, via CAS Intelligence Hub^SM, to organize and standardize Novartis’ extensive collection of experimental reaction data, helping make these valuable research data assets more readily accessible for computational research, machine learning, and AI applications.

“This exciting collaboration reflects the critical importance of a strong scientific data infrastructure, alongside domain-specific technology and expertise, to enable today’s rapidly evolving drug discovery workflows,” said Tim Wahlberg, Interim President, CAS. “We are pleased to extend our long-standing relationship with Novartis to help make this data a more accessible and valuable AI-ready resource.” 

As part of this project, CAS will also collaborate with Novartis to develop a customized discovery platform built on the CAS SciFinder® architecture. This platform is designed to enable Novartis researchers to search, analyze, and cross-reference their enriched internal reaction data and CAS data simultaneously. By addressing a long-standing challenge of efficiently and comprehensively searching internal and external data together, this effort also lays the foundation for future CAS platform capabilities, including large language models and agentic AI. 

About CAS 

CAS connects the world’s scientific knowledge to accelerate breakthroughs that improve lives. We are the scientific data intelligence partner empowering global innovators to capture the promise of AI and achieve real-world results. CAS builds the world’s largest collection of scientist-curated data. That foundation underpins our portfolio of science-smart insights platforms and integrates with R&D workflows for more confident decisions and reliable predictions. As a pioneer at the intersection of scientific data and AI-driven discovery, CAS enables leaders in life sciences, chemistry, and materials with the unique capabilities and expertise that deliver transformative innovation. CAS is a division of the American Chemical Society. Connect with us at cas.org. 

Media Contacts 

Peter Carlton 

Senior Communications Manager, CAS 

CAS-PR@cas.org

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cas-announces-collaboration-with-novartis-to-advance-ai-ready-reaction-informatics-302889982.html